Pharmakon Pharmaceuticals, Inc. FDA Inspection Record
Pharmakon Pharmaceuticals, Inc. is an FDA-inspected facility (FEI 3008213711) located in Noblesville, IN, US. RegDataLab tracks 3 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Mar 16, 2016: Official Action Indicated (OAI)
- Inspections on record
- 3 (3 OAI)
- Last OAI inspection
- Mar 16, 2016
- Warning letters
- 1 listed by FDA for this FEI, latest May 21, 2015
- Form 483 and inspection documents
- 4 in FDA's reading room
- Recalls as the recalling firm
- 5, latest Apr 20, 2016
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 16, 2016 | Official Action Indicated (OAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Clothing appropriate for duties performed (21 CFR 211.28(a)) Penicillin processing area not kept separate (21 CFR 211.42(d)) Air Supply (21 CFR 211.42(c)(10)(iii)) and 8 more |
| Apr 8, 2014 | Official Action Indicated (OAI) | SOPs not followed / documented (21 CFR 211.100(b)) Examination of packaging and labeling (21 CFR 211.130(d)) Examinations documented (21 CFR 211.134(c)) Signature and checking of records -- 2 persons (21 CFR 211.186(a)) and 2 more |
| Mar 13, 2014 | Official Action Indicated (OAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Apr 20, 2016 | Class II | D-1256-2016 | Phenylephrine 40 mcg/mL injection in 0.9% Sodium Chloride 10 mL syringe, Rx Only… and 88 more products Lack of Assurance of Sterility |
| Feb 11, 2016 | Class I | D-0871-2016 | Morphine Sulfate 0.5 mg/mL, Preservative Free in 0.9% Sodium Chloride, Rx, total volume 1… Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj. |
| Aug 19, 2015 | Class II | D-0588-2016 | Ephedrine Sulfate 5 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total… and 21 more products Stability data does not support expiry. |
| Apr 21, 2014 | Class I | D-1565-2014 | Midazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC Vial, Rx Only. Pharmakon… and 3 more products Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. |
| Mar 26, 2014 | Class I | D-1362-2014 | Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx… Superpotent Drug: Product contains twice the stated amount of midazolam. |
Form 483s and inspection documents
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
9 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall D-1256-2016, this FEI as the recalling firm | Apr 20, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Mar 16, 2016 | 10 years or older, so it adds no points | 0 |
| Class I recall D-0871-2016, this FEI as the recalling firm | Feb 11, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0588-2016, this FEI as the recalling firm | Aug 19, 2015 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | May 21, 2015 | 10 years or older, so it adds no points | 0 |
| Class I recall D-1565-2014, this FEI as the recalling firm | Apr 21, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Apr 8, 2014 | 10 years or older, so it adds no points | 0 |
| Class I recall D-1362-2014, this FEI as the recalling firm | Mar 26, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Mar 13, 2014 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing Pharmakon Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Pharmakon Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Pharmakon Pharmaceuticals, Inc.
- Location
- Noblesville, IN (US)
- Source
- inspections